View : 204 Download: 24
The Impact of the Rapid Blood Culture Identification Panel on Antibiotic Treatment and Clinical Outcomes in Bloodstream Infections, Particularly Those Associated with Multidrug-Resistant Micro-Organisms
- Title
- The Impact of the Rapid Blood Culture Identification Panel on Antibiotic Treatment and Clinical Outcomes in Bloodstream Infections, Particularly Those Associated with Multidrug-Resistant Micro-Organisms
- Authors
- Bae; Ji-Yun; Jiyeon; So; Min-Kyung; Choi; Hee-Jung; Lee; Miae
- Ewha Authors
- 이미애; 최희정; 배지윤; 소민경
- SCOPUS Author ID
- 이미애; 최희정; 배지윤; 소민경
- Issue Date
- 2023
- Journal Title
- Diagnostics
- ISSN
- 2075-4418
- Citation
- Diagnostics vol. 13, no. 23
- Keywords
- antimicrobial drug resistance; bacteremia; blood culture; multiplex polymerase chain reaction
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- We evaluated the impact of the FilmArray blood culture identification (BCID) panel on the time taken to administer effective antibiotics and the clinical outcomes of bloodstream infections. We retrospectively screened patients with bloodstream infections who underwent BCID testing and compared them to a historical control group that received conventional culture testing. A total of 144 and 214 patients who underwent BCID and conventional cultures, respectively, were compared. The 30-day mortality (BCID: 9.7% vs. conventional method: 10.7%, p = 0.755), time to effective antibiotic administration (3 h for both BCID and conventional method, p = 0.789), and time to appropriate antibiotic administration did not differ significantly between the groups. BCID was not significantly associated with 30-day mortality after adjusting for the Pitt bacteremia score and the Charlson comorbidity index (adjusted OR = 0.833, CI; 0.398–1.743). Compared with conventional methods, BCID reduced the time to administration of effective antibiotics in cases of carbapenem-resistant Enterobacterales (CRE) (39 h vs. 93 h, p = 0.012) and vancomycin-resistant enterococci (VRE) (50 h vs. 92 h, p < 0.001) bacteremia. BCID did not affect the clinical outcomes of overall bloodstream infections; however, it contributed to the early administration of effective antibiotics in cases of CRE and VRE bacteremia. © 2023 by the authors.
- DOI
- 10.3390/diagnostics13233504
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
-
diagnostics-13-03504.pdf(737.7 kB)
Download
- Export
- RIS (EndNote)
- XLS (Excel)
- XML